6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Psychiatric Comorbidities in Addiction Disorders
Addiction often coexists with psychiatric disorders, such as anxiety, depression, and schizophrenia, complicating diagnosis and treatment. Known as dual diagnosis, these co-occurring conditions require an integrated treatment approach. Substance abuse can exacerbate mental health symptoms, while psychiatric disorders can increase vulnerability to addiction. Effective management involves simultaneous treatment of both conditions using a combination of medication, psychotherapy, and lifestyle changes. Understanding the bidirectional relationship between addiction and mental health is crucial for developing personalized treatment plans. Addressing psychiatric comorbidities can significantly improve recovery outcomes and quality of life for affected individuals.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States